Document is current
Any future updates will be listed below
-
Authors
Brastianos, Priscilla K.
Nayyar, Naema
Rosebrock, Daniel
Leshchiner, Ignaty https://orcid.org/0000-0001-8942-9265
Gill, Corey M.
Livitz, Dimitri https://orcid.org/0000-0003-2528-1446
Bertalan, Mia S.
D’Andrea, Megan
Hoang, Kaitlin
Aquilanti, Elisa
Chukwueke, Ugonma N.
Kaneb, Andrew
Chi, Andrew
Plotkin, Scott
Gerstner, Elizabeth R.
Frosch, Mathew P.
Suva, Mario L. https://orcid.org/0000-0001-9898-5351
Cahill, Daniel P.
Getz, Gad https://orcid.org/0000-0002-0936-0753
Batchelor, Tracy T.
- License Information
-
More Information
Article History
Received: 7 March 2017
Revised: 1 August 2017
Accepted: 2 August 2017
First Online: 18 September 2017
Competing interests
: Dr. Batchelor has consulted for Merck, NXDC and Amgen. Dr. Brastianos has consulted for Merck, Genentech-Roche, Angiochem and Lilly.
